In this study, we found that STMN1 can activate the p38MAPK/STAT1 signaling pathway and that inhibiting the activity of the p38MAPK/STAT1 signaling pathway could reverse the promoting effect of STMN1 on NSCLC metastasis. This evidence concerns the gene STMN1 and non-small cell lung carcinoma.